RHYTHM PHARMACEUTICALS, INC. Balance Sheet
RYTM / Health Care|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
RHYTHM PHARMACEUTICALS, INC. had $480M in total assets and $139M in shareholders' equity as of FY2025. Total debt was $101M against $54M in cash, resulting in $47M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54.3M | $89.1M | $60.1M | $127.7M | $59.2M | $100.9M | $62.3M | $49.5M | $34.2M | $6.5M | $34.9M |
| Accounts Receivable | $26.1M | $18.5M | $14.9M | $6.2M | $1.0M | - | - | - | - | - | - |
| Inventory | $25.8M | $18.7M | $8.6M | $2.9M | $111.0K | - | - | - | - | - | - |
| Current Assets | $466.9M | $374.2M | $308.3M | $354.2M | $308.4M | $181.7M | $302.4M | $258.7M | $150.7M | $11.2M | - |
| PP&E (Net) | $1.1M | $632.0K | $1.3M | $2.2M | $2.8M | $3.2M | $3.7M | $1.1M | $840.0K | $930.0K | - |
| Total Assets | $480.2M | $392.3M | $332.7M | $382.5M | $329.5M | $187.1M | $308.5M | $260.2M | $151.7M | $12.3M | - |
| Current Liabilities | $105.9M | $115.5M | $55.2M | $39.8M | $43.4M | $18.0M | $24.4M | $13.6M | $6.7M | $4.7M | - |
| Total Debt | $100.9M | $108.3M | $106.1M | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $139.1M | $21.7M | $169.8M | $264.3M | $284.2M | $166.5M | $281.0M | $246.3M | $144.8M | -$32.7M | -$8.0M |